1. Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma
   Yushi Ueki et al, 2024, International Journal of Clinical Oncology CrossRef